Tumor-Infiltrating Lymphocytes/Plasmocytes in Chemotherapeutically Non-Influenced Triple-Negative Breast Cancers - Correlation with Morphological and Clinico-Pathological Parameters
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
31610672
DOI
10.14735/amko2019380
PII: 115517
Knihovny.cz E-resources
- Keywords
- Bcl-2, clinico-pathological parameters, malignant neoplasm of breast, mastectomy, triple-negative breast neoplasms, tumor infiltrating lymphocytes, tumor morphology,
- MeSH
- Ki-67 Antigen metabolism MeSH
- Drug Resistance, Neoplasm MeSH
- Middle Aged MeSH
- Humans MeSH
- Mastectomy MeSH
- Neoadjuvant Therapy MeSH
- Prognosis MeSH
- Proto-Oncogene Proteins c-bcl-2 metabolism MeSH
- Neoplasm Grading MeSH
- Triple Negative Breast Neoplasms * immunology metabolism pathology therapy MeSH
- Lymphocytes, Tumor-Infiltrating * MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Ki-67 Antigen MeSH
- BCL2 protein, human MeSH Browser
- MKI67 protein, human MeSH Browser
- Proto-Oncogene Proteins c-bcl-2 MeSH
BACKGROUND: Triple-negative breast cancers (TNBCs) are considered a morphologically heterogeneous group of breast carcinomas characterized by the absence or low protein expression of hormone receptors and HER2/neu/ERBB2 with a specific biological behavior and therapeutic response. This study aimed to evaluate correlations of the density of tumor-infiltrating lymphocytes/plasmocytes (TILs) in the tumor parenchyma, stroma, and invasive margins with tumor morphology, the proliferation rate, Bcl-2 expression, and selected clinical and pathological parameters in early breast cancer patients prior to mastectomy who had not received initial chemotherapy. MATERIALS AND METHODS: Samples of 3,544 breast cancer patients investigated in our department between 2007 and 2017 were re-examined. In total, 413 (11.65%) patients were diagnosed with TNBC. Only 61 cases did not undergo neoadjuvant therapy prior to mastectomy. Correlations between the density of TILs and tumor morphology, Bcl-2 expression, proliferative activity measured by Ki-67, patient age at diagnosis, tumor grade, and metastases were investigated. RESULTS: The samples were predominantly relatively well-localized invasive carcinomas of no special type with medullary features (80.32%) that measured on average 13.4mm (range 5-20mm, median 15mm) and exhibited central necrosis or fibrosis, a tendency to undergo spindle cell and/or apocrine-like differentiation, and intensive infiltration of TILs. There were significant positive correlations between TILs and premenopausal status (p=0.003), Ki-67 expression (p=0.015), and tumor grade (p=0.002), a marginal positive correlation between TILs and tumor size (p=0.065), and a significant negative correlation between TILs and Bcl-2 expression (p=0.035). In younger patients (< 50 years) with tumor size less than or equal to 20 mm (pT1a-pT1c) we recorded a lower number of women with metastatic lymph node involvement (p=0.001). CONCLUSION: The density and location of TILs in non-therapeutically influenced TNBCs, evaluated in the context of morphological changes and other clinicopathological parameters, may have prognostic significance and assist effective therapy planning.
References provided by Crossref.org